Company registration number: 12517092
Unaudited financial statements
for the year ended 31 March 2025
for
Lilac Medical Ltd
Pages for filing with the Registrar
Company registration number: 12517092
Lilac Medical Ltd
Balance sheet
as at 31 March 2025
2025 2024
Note £ £ £ £
Fixed assets
Tangible assets 4 340 400
340 400
Current assets
Cash at bank and in hand 31,597 13,737
31,597 13,737
Creditors: amounts falling due within one
year
(4,669) (2,285)
Net current assets 26,928 11,452
Total assets less current liabilities 27,268 11,852
NET ASSETS 27,268 11,852
Capital and reserves
Called up share capital 10 10
Profit and loss account 27,258 11,842
TOTAL EQUITY 27,268 11,852
The company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies for the year ended 31 March 2025.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges their responsibilities to comply with the Companies Act 2006 in respect to accounting records and the preparation of financial statements.
1
Company registration number: 12517092
Lilac Medical Ltd
Balance sheet - continued
as at 31 March 2025
The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
In accordance with Section 444 of the Companies Act 2006, the Profit and loss account has not been delivered to the Registrar.
Signed by:
Dr S Croft, Director
9 May 2025
2
Lilac Medical Ltd
Notes to the financial statements
for the year ended 31 March 2025
1 Company information
Lilac Medical Ltd is a private company registered in England and Wales. Its registered number is 12517092. The company is limited by shares. Its registered office is 4A Slayleigh Lane, Fulwood, Sheffield, South Yorkshire, S10 3RF.
2 Accounting policies
Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” including the provisions of Section 1A “Small Entities” and the Companies Act 2006. The financial statements have been prepared under the historic cost convention.
Going concern
In preparing these financial statements, the director has assessed whether there are any material uncertainties related to events or conditions that cast significant doubt upon the company's ability to continue as a going concern. In making this assessment, the director takes into account all available information about the future which is at least 12 months from the date that the financial statements are authorised for issue.
The director considers that the company has adequate resources to continue in business for the foreseeable future and that it is appropriate to adopt the going concern basis in preparing the financial statements.
Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, Value Added Tax and other sales taxes.
Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life or, if held under a finance lease, over the lease term, whichever is the shorter.
Plant and machinery etc.:
Computer Equipment - 15% reducing balance
Taxation
Taxation for the year comprises current taxation. Tax is recognised in the Profit and loss account, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.
Current taxation assets and liabilities are not discounted.
Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.
3 Average number of employees
During the year the average number of employees was 1 (2024 - 1).
3
Lilac Medical Ltd
Notes to the financial statements - continued
for the year ended 31 March 2025
4 Tangible fixed assets
Plant and
machinery
etc.
£
Cost
At 1 April 2024 759
At 31 March 2025 759
Depreciation
At 1 April 2024 359
Charge for year 60
At 31 March 2025 419
Net book value
At 31 March 2025 340
At 31 March 2024 400
4